About Meridian Drug Discovery

Meridian Drug Discovery is the one-stop for conducting business in a scientific environment. Our partners are the leaders in the USA and Europe’s academic, scientific, and business world. Our areas of interest include helping to accelerate pipelines, acquire funding, finding service providers, and grasp unique partnership opportunities.
We centralize our scientific approach to assist in the design, strategy, and model of the study. As a technology-driven organization, the goal is to create an economical and efficient model that can reduce the cost and timeline of the discovery study. The program covers Study Design, target identification, validation, assay development, Nex Generation Sequencing, in vitro, in vivo, and PK-PD. Meridian Drug Discovery focuses on the utilization of synthesis libraries and artificial intelligence in computer-aided design to speed up the process. It’s a one-stop for the leaders from pharma-biotech, universities, research centers, and non-profit organizations to enhance their knowledge and professional network.
0 +
One to One Meetings
0 +
0 +
Networking Hours
0 +
Keynote Speakers

Learn About Event Speakers

Nagendra Chemuturi

Scientific Director Research

Afreen Allam


Vivek K Vishnudas

Senior Vice President Drug Discovery

Hala Kaaki

Head of Orphan Diseases Division

Yong Yue

Sr. Director, Computational Biology and Data Sciences

Rangaprasad Sarangarajan

Chief Scientific Officer & SVP Clinical and Translational Sciences

James Leamon

Director, Biologics Device Development


Enhance your knowledge Enhance your capabilities

Learn from the industry’s top leading professionals. Increase your knowledge and partners under one roof

  • 08.00 - 09.00 AM

    Registration and Chairperson’s Opening

  •  Dr. Aude Segaliny 09.00 - 09.30 AM
    Dr. Aude Segaliny

    Presentation 1

    Higher order structure and molecular mechanism of action analysis for accelerated drug design

  •  Afreen Allam 09.30 - 10.00 Am
    Afreen Allam

    Presentation 2

    Target Identification; linking target and chemical properties to desired product pipeline.

  • 10:00 - 10:30 pm

    Presentation 3

    Drug Targets with Genomic Support: A Genomics-based Strategic Framework for Improving Target Discovery and Accelerating Drug Development

  • 08.00 - 09.00 AM

    Registration and Chairperson’s Opening

  • 9:00 - 9:30 AM

    Presentation 1

    Benefits, limitations, and diversity of AI model in drug and target discovery.

  • 9:30 - 10:00 AM

    Presentation 2

    Deep generative autopilot for the real world design of novel lead compound.

  • 10:00 - 10:30 AM

    Presentation 3

    Complexity simplified; comprehensive data management for complex world.

Why Attend Event Be Our Partner

The Sponsorship opportunity at Meridian Drug Discovery come with countless benefits.


Meetings, meet with industry's most renowned decision-makers exclusively. Dine and discuss business in a private setting; competitor friendly atmosphere.



The exhibition, deliver yourself from the irrelevant audience, surround yourself with the right decision-makers in a business-driven environment; choose quality over quantity.



Presentation, Devote yourself to science, feed the next generation with experience-based knowledge. Grasp the opportunity to apprise yourself and your organization.



Networking, a new partner, the next funding, is just one introduction away. introduce yourself to the right people in the right place. Initiate a new business relationship by being in the right place at the right time.


Projected Decision Makers

Conscientiously selected content, we only enlist the decision-makers with admissible job capacity, pledged for Drug Discovery in their organizations.

Send Message

    HURRY UP! Book your Slot


    Want Something Extra?